Abstract:Objective: Suboptimal mitochondrial function has been implicated in several disorders in which fatigue is a prominent feature. Vitamin D deficiency is a well-recognized cause of fatigue and myopathy. The aim of this study was to examine the effects of cholecalciferol therapy on skeletal mitochondrial oxidative function in symptomatic, vitamin D-deficient individuals.Design: This longitudinal study assessed mitochondrial oxidative phosphorylation in the gastrosoleus compartment using phosphorus-31 magnetic reso… Show more
“…The differentially expressed mRNAs encode proteins that play significant roles in multiple biochemical pathways involved in muscle contraction and relaxation; extracellular matrix-cell receptor interactions; actin cytoskeleton remodeling; and JAK-STAT, insulin-like (17) 0.014 Reactome p53 pathway (16) 0.014 Panther Interferon-signaling (11) 0.017 Panther Muscle contraction (9) 0.022 Reactome Terpenoid backbone biosynthesis (6) 0.028 KEGG Cell adhesion molecules (24) 0.048 KEGG (27), which showed that treatment of vitamin D-deficient humans with cholecalciferol improves muscle phosphocreatine recovery after exercise, suggesting an effect of 1␣,25(OH) 2 D 3 on the formation of high energy phosphorylated intermediates and mitochondrial function. The increase in the numbers of mitochondria could also account for the increase in cellular OCR.…”
Section: Discussionmentioning
confidence: 99%
“…Many reports suggest that the vitamin D receptor (VDR) is expressed in skeletal muscle (20 -24), and VDR deletion in mice results in alterations in muscle function and strength (25,26). Treatment of vitamin D-deficient humans with cholecalciferol improves muscle phosphocreatine recovery after exercise (27), suggesting that vitamin D 3 or its metabolites alter skeletal muscle oxidative capacity.…”
Previous reports have shown that in avian and rodent isolated skeletal muscle cells and cultured myoblast cell lines, vitamin D 3 metabolites, such as 25-hydroxyvitamin D 3 (25(OH)D 3 ) and 1␣,25(OH) 2 D 3 , influence cellular calcium and phosphorus uptake, cellular growth, differentiation, and the expression of a limited number of genes (14 -19). Many reports suggest that the vitamin D receptor (VDR) is expressed in skeletal muscle (20 -24), and VDR deletion in mice results in alterations in muscle function and strength (25,26). Treatment of vitamin D-deficient humans with cholecalciferol improves muscle phosphocreatine recovery after exercise (27), suggesting that vitamin D 3 or its metabolites alter skeletal muscle oxidative capacity.To assess the mechanism of action of the active metabolite of vitamin D 3 , 1␣,25(OH) 2 D 3 , in human skeletal muscle cells, we examined changes in mitochondrial oxygen consumption (OCR), mitochondrial dynamics, mitochondrial OXPHOS proteins, pyruvate dehydrogenase phosphorylation, and nuclear gene expression using whole transcriptome shotgun sequencing (WTSS, RNA-seq) of messenger RNAs and micro-RNAs Tables 1 and 2
“…The differentially expressed mRNAs encode proteins that play significant roles in multiple biochemical pathways involved in muscle contraction and relaxation; extracellular matrix-cell receptor interactions; actin cytoskeleton remodeling; and JAK-STAT, insulin-like (17) 0.014 Reactome p53 pathway (16) 0.014 Panther Interferon-signaling (11) 0.017 Panther Muscle contraction (9) 0.022 Reactome Terpenoid backbone biosynthesis (6) 0.028 KEGG Cell adhesion molecules (24) 0.048 KEGG (27), which showed that treatment of vitamin D-deficient humans with cholecalciferol improves muscle phosphocreatine recovery after exercise, suggesting an effect of 1␣,25(OH) 2 D 3 on the formation of high energy phosphorylated intermediates and mitochondrial function. The increase in the numbers of mitochondria could also account for the increase in cellular OCR.…”
Section: Discussionmentioning
confidence: 99%
“…Many reports suggest that the vitamin D receptor (VDR) is expressed in skeletal muscle (20 -24), and VDR deletion in mice results in alterations in muscle function and strength (25,26). Treatment of vitamin D-deficient humans with cholecalciferol improves muscle phosphocreatine recovery after exercise (27), suggesting that vitamin D 3 or its metabolites alter skeletal muscle oxidative capacity.…”
Previous reports have shown that in avian and rodent isolated skeletal muscle cells and cultured myoblast cell lines, vitamin D 3 metabolites, such as 25-hydroxyvitamin D 3 (25(OH)D 3 ) and 1␣,25(OH) 2 D 3 , influence cellular calcium and phosphorus uptake, cellular growth, differentiation, and the expression of a limited number of genes (14 -19). Many reports suggest that the vitamin D receptor (VDR) is expressed in skeletal muscle (20 -24), and VDR deletion in mice results in alterations in muscle function and strength (25,26). Treatment of vitamin D-deficient humans with cholecalciferol improves muscle phosphocreatine recovery after exercise (27), suggesting that vitamin D 3 or its metabolites alter skeletal muscle oxidative capacity.To assess the mechanism of action of the active metabolite of vitamin D 3 , 1␣,25(OH) 2 D 3 , in human skeletal muscle cells, we examined changes in mitochondrial oxygen consumption (OCR), mitochondrial dynamics, mitochondrial OXPHOS proteins, pyruvate dehydrogenase phosphorylation, and nuclear gene expression using whole transcriptome shotgun sequencing (WTSS, RNA-seq) of messenger RNAs and micro-RNAs Tables 1 and 2
“…They involve the rapid regulation of membrane calcium channels, suggesting a role for vitamin D in the calcium‐mediated muscle functions, such as muscle contraction and mitochondrial function, which leads to an adequate insulin signalling and muscle substrate metabolism 42. All these findings may clarify the relationship between low vitamin D status and muscle weakness,37, 43 intramuscular fat deposition,44 and resistance to insulin,45 which is related to cardiovascular risk and increased skeletal muscle breakdown 46.…”
The spectrum of activity of vitamin D goes beyond calcium and bone homeostasis, and growing evidence suggests that vitamin D contributes to maintain musculoskeletal health in healthy subjects as well as in patients with chronic kidney disease (CKD), who display the combination of bone metabolism disorder, muscle wasting, and weakness. Here, we review how vitamin D represents a pathway in which bone and muscle may interact. In vitro studies have confirmed that the vitamin D receptor is present on muscle, describing the mechanisms whereby vitamin D directly affects skeletal muscle. These include genomic and non‐genomic (rapid) effects, regulating cellular differentiation and proliferation. Observational studies have shown that circulating 25‐hydroxyvitamin D levels correlate with the clinical symptoms and muscle morphological changes observed in CKD patients. Vitamin D deficiency has been linked to low bone formation rate and bone mineral density, with an increased risk of skeletal fractures. The impact of low vitamin D status on skeletal muscle may also affect muscle metabolic pathways, including its sensitivity to insulin. Although some interventional studies have shown that vitamin D may improve physical performance and protect against the development of histological and radiological signs of hyperparathyroidism, evidence is still insufficient to draw definitive conclusions.
“…Very recently the beneficial effect of vitamin D on oxidative phosphorylation was shown, giving a clue for the possible mechanism of vitamin D associated fatigue and muscle weakness [13].…”
Background: Vitamin D is well known for its role in calcium homeostasis and bone metabolism. In addition 25 (OH) vitamin D3 (25OHD3) deficiency is correlated with muscle pain and weakness, hence there is increasing interest in optimal 25OHD3 levels for athletes. We investigated the prevalence of 25OHD3 deficiency and the ethnical variation in 25(OH)D concentrations among professional soccer players in the winter season.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.